|
The Boeing Company
March 18, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Boeing Company (“Boeing” or the “Company”) (NYSE: BA). Investors who purchased Boeing securities may be affected.
|
|
U.S. Xpress Enterprises, Inc.
March 18, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of U.S. Xpress Enterprises, Inc. (“U.S. Xpress” or the “Company”) (NYSE: USX). An action has been filed on behalf of investors who purchased or otherwise acquired U.S. Xpress common stock pursuant and/or traceable to the Company’s June 2018 initial public offering (the “IPO”).
|
|
United Microelectronics Corporation
March 18, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of United Microelectronics Corporation (“UMC” or the “Company”) (NYSE: UMC). Investors who purchased or otherwise acquired UMC’s American Depositary Shares (ADSs) or other UMC securities between October 28, 2015 and November 1, 2018, inclusive (the “Class Period”), may be affected. A complaint has been filed in the United States District Court for the Southern District of New York against the Company and certain executives.
|
|
Eventbrite, Inc.
March 11, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Eventbrite, Inc. (“Eventbrite” or the “Company”) (NYSE: EB). Investors who purchased Eventbrite securities may be affected.
|
|
American Renal Associates Holdings, Inc.
March 11, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of American Renal Associates Holdings, Inc. (“American Renal” or the “Company”) (NYSE: ARA), a company that through its subsidiaries owns and operates kidney dialysis centers. Investors that purchased American Renal securities may be affected.
|
|
CenturyLink, Inc.
March 11, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CenturyLink, Inc. (“CenturyLink” or the “Company”) (NYSE: CTL). Investors who purchased CenturyLink securities between May 10, 2018 and March 4, 2019, inclusive (the “Class Period”), may be affected. A complaint has been filed in the United States District Court for the Central District of California against the Company and certain executives (the “Action”).
|
|
Healthcare Services Group, Inc.
March 6, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Healthcare Services Group, Inc. (Nasdaq: HCSG).
|
|
Nio Inc.
March 6, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Chinese electric carmaker Nio Inc. (NYSE: NIO).
|
|
FTS International, Inc.
March 4, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of FTS International, Inc. (“FTS” or the “Company”) (NYSE: FTSI), purportedly one of the largest providers of hydraulic fracturing services in North America. A complaint has been filed against the Company, certain officers and directors, and the underwriters of the Company’s February 2018 initial public offering (“IPO”) alleging that the Registration Statement and other offering documents for the IPO were materially false and misleading.
|
|
Syneos Health, Inc.
February 28, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Syneos Health, Inc. (Nasdaq: SYNH).
|
|
Stamps.com
February 26, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Stamps.com Inc. (“Stamps.com” or the “Company”) (NASDAQ: STMP). Investors who purchased Stamps.com securities may be affected.
|
|
Diplomat Pharmacy, Inc.
February 22, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Diplomat Pharmacy, Inc. (“Diplomat Pharmacy” or the “Company”) (NYSE: DPLO), a specialty pharmacy company. Investors who purchased or otherwise acquired Diplomat Pharmacy’s publicly traded securities may be affected.
|
|
Health Insurance Innovations, Inc.
February 21, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Health Insurance Innovations, Inc. (“Health Insurance Innovations”, “HIIQ” or the “Company”) (NASDAQ: HIIQ), a company that purportedly distributes individual and family health insurance plans, including short-term medical insurance plans, and guaranteed-issue and underwritten health benefit insurance plans. Investors who purchased Health Insurance Innovations securities between February 28, 2018 and November 27, 2018, inclusive (the “Class Period”), may be affected. A complaint has been filed in the United States District Court for Middle District of Florida against the Company and certain executives (the “Action”).
|
|
Synergy Pharmaceuticals Inc.
February 20, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Synergy Pharmaceuticals Inc. (“Synergy” or the “Company”) (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of therapies to treat Gastro-Intestinal disorders and diseases. Investors who purchased Synergy securities between September 7, 2017 and October 25, 2018, inclusive (the “Class Period”), may be affected. A complaint has been filed in the United States District Court for the Eastern District of New York against certain Synergy executives.
|
|
CPI Aerostructures Inc.
February 19, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of CPI Aerostructures Inc. (NYSE: CVU).
|
|
Mattel, Inc.
February 19, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Mattel, Inc. (Nasdaq: MAT). Purchasers of Mattel securities between February 8 and 15, 2019 may be affected.
|
|
Uxin Limited
February 14, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Uxin Limited (“Uxin” or the “Company”) (NASDAQ: UXIN), a Chinese company that operates an e-commerce platform for buying and selling cars. A complaint has been filed in the United States District Court for the Eastern District of New York against the Company, certain executives and the underwriters of Uxin’s June 2018 initial public offering (“IPO”) on behalf of investors who purchased or otherwise acquired Uxin’s publicly traded securities pursuant to and/or traceable to the Company’s IPO.
|
|
Bristow Group Inc.
February 14, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Bristow Group Inc. (NYSE: BRS).
|
|
Astec Industries, Inc.
February 14, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Astec Industries, Inc. (“Astec” or the “Company”) (NASDAQ: ASTE). Investors who purchased Astec stock between July 26, 2016 and October 22, 2018, inclusive (the “Class Period”), may be affected. A complaint has been filed in the United States District Court for the Eastern District of Tennessee against Astec, its Chief Executive Officer and its Chief Financial Officer on behalf of investors of Astec stock during the Class Period.
|
|
Arlo Technologies, Inc.
February 11, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Arlo Technologies, Inc. (“Arlo” or the “Company”) (NYSE: ARLO), a company that provides smart connected devices, such as security cameras. A complaint has been filed against the Company and certain executives in the United States District Court for the Northern District of California on behalf of investors who purchased Arlo common stock pursuant or traceable to Arlo’s August 2018 initial public offering (the “IPO”).
|
|
Helius Medical Technologies, Inc.
February 7, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Helius Medical Technologiues, Inc. (“Helius” or the “Company”) (Nasdaq: HSDT).
|
|
Cavco Industries, Inc.
February 7, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Cavco Industries, Inc. (“Cavco” or the “Company”) (Nasdaq: CVCO).
|
|
Corcept Therapeutics Incorporated
February 5, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ : CORT).
|
|
Wirecard AG
February 1, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Wirecard AG (“Wirecard” or the “Company”) (OTC: WCAGY, WRCDF), an online payment processing company based in Europe, concerning potential securities law violations. Investors who purchased Wirecard securities may be affected.
|
|
22nd Century Group, Inc.
January 28, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of 22nd Century Group, Inc. (“22nd Century” or the “Company”) (NYSE American: XXII). Investors who purchased 22nd Century securities between February 18, 2016 and October 25, 2018, inclusive (the “Class Period”), may be affected. A complaint has been filed in the United States District Court for the Eastern District of New York on behalf of investors of 22nd Century securities during the Class Period.
|
|
Ferroglobe PLC
January 28, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Ferroglobe PLC (“Ferroglobe” or the “Company”) (NASDAQ: GSM), purportedly one of the world’s largest producers of silicon metal, silicon-based alloys and manganese-based alloys. Investors who purchased Ferroglobe securities between August 21, 2018 and November 26, 2018, inclusive (the “Class Period”), may be affected.
|
|
Amdocs Limited
January 23, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Amdocs Limited (“Amdocs” or the “Company”) (Nasdaq: DOX).
|
|
YRC Worldwide Inc.
January 24, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of YRC Worldwide Inc. (“YRC” or the “Company”) (NASDAQ: YRCW), a company that provides various transportation services primarily in North America. Investors who purchased or otherwise acquired YRC securities between March 10, 2014 and December 14, 2018, inclusive (the “Class Period”), may be affected. A complaint has been filed in the United States District Court for the Northern District of New York against YRC and certain executives on behalf of investors in YRC securities during the Class Period.
|
|
Snap, Inc.
January 16, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Snap, Inc. (“Snap” or the “Company”) (NYSE: SNAP). Investors who purchased Snap common stock between March 2, 2017 and August 10, 2017, inclusive (the “Class Period”) may be affected.
|
|
Danske Bank A/S
January 24, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Danske Bank A/S American Depository Shares (“Danske” or the “Company”) (OTC: DNKEY) (CUSIP: 236363206).
|
